|
Volumn 8, Issue 2, 2009, Pages 139-142
|
All things mucosal
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOVIRUS VECTOR;
CD4 ANTIGEN;
CHEMOKINE RECEPTOR CCR7;
CHOLERA TOXIN;
CHOLERA VACCINE;
CPG OLIGODEOXYNUCLEOTIDE;
CYANOVIRIN N;
DNA VACCINE;
ENTEROTOXIN;
FLAGELLIN;
HUMAN IMMUNODEFICIENCY VIRUS PROTEIN;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOLOGICAL ADJUVANT;
INTERLEUKIN 13;
INTERLEUKIN 1BETA;
INTERLEUKIN 4;
MACROPHAGE INFLAMMATORY PROTEIN 3BETA;
MICROBICIDE;
OLEIC ACID;
RETINOIC ACID;
SECONDARY LYMPHOID TISSUE CHEMOKINE;
VACCINE;
ANTIBODY TITER;
ANTIGEN SPECIFICITY;
CONFERENCE PAPER;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SAFETY;
HUMAN;
IMMUNE RESPONSE;
IMMUNIZATION;
IMMUNOLOGICAL TOLERANCE;
MUCOSAL IMMUNITY;
NONHUMAN;
PRIORITY JOURNAL;
TH1 CELL;
TH2 CELL;
ADJUVANTS, IMMUNOLOGIC;
ANTI-INFECTIVE AGENTS;
HUMANS;
IMMUNITY, MUCOSAL;
MUCOUS MEMBRANE;
PORTUGAL;
VACCINES;
|
EID: 60149101399
PISSN: 14760584
EISSN: 17448395
Source Type: Journal
DOI: 10.1586/14760584.8.2.139 Document Type: Conference Paper |
Times cited : (1)
|
References (0)
|